Extreme Exercise and Energy Expenditure (4E) Study

计划入组 13 人 · 首次发布于 2023 年 6 月 9 日

The Involvement of Eukaryotic Translation Initiation Factor 4E (eIF4E) in Human Placental Implantation and in the Pathological Pregnancies: Preeclampsia and IUGR

首次发布于 2010 年 8 月 11 日

A Prospective, Randomized Controlled Trial Comparing Traditional Methods of Neuromuscular Block Reversal to Sugammadex for Extubation in the Operating Room in ASA 4 and 4E Patients

计划入组 130 人 · 首次发布于 2013 年 1 月 4 日

[18F]4e(AstraZeneca)

DUX4 miRNA therapy (MyoAAV, facioscapulohumeral dystrophy)

DUX4 miRNA Therapy (MyoAAV) (Kate Therapeutics)

Gimon Yoav

Israel

Dyno Therapeutics Unveils AI-Engineered AAV Vector Dyno-bn8 for Muscle Gene Therapy with 25-Fold Dose Reduction

Lilly Acquires 4E Therapeutics to Advance Non-Opioid MNK Inhibitor Pipeline for Chronic Pain

Scientists Uncover New Druggable Site on eIF4E Protein, Opening Path for Novel Cancer Therapeutics